| 1 |
Dey A, Vaishak K, Deka D, Radhakrishnan AK, Paul S, Shanmugam P, Daniel AP, Pathak S, Duttaroy AK, Banerjee A. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review. Infection 2023;:1-16. [PMID: 36906872 DOI: 10.1007/s15010-023-02017-8] [Reference Citation Analysis]
|
| 2 |
Prasad R, Adu-Agyeiwaah Y, Floyd JL, Asare-Bediako B, Li Calzi S, Chakraborty D, Harbour A, Rohella A, Busik JV, Li Q, Grant MB. Sustained ACE2 Expression by Probiotic Improves Integrity of Intestinal Lymphatics and Retinopathy in Type 1 Diabetic Model. J Clin Med 2023;12. [PMID: 36902558 DOI: 10.3390/jcm12051771] [Reference Citation Analysis]
|
| 3 |
Simões JLB, Sobierai LD, Leal IF, Dos Santos MVR, Coiado JV, Bagatini MD. Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer's Disease in the Context of the COVID-19 Pandemic. Neuroscience 2023;512:110-32. [PMID: 36526078 DOI: 10.1016/j.neuroscience.2022.12.007] [Reference Citation Analysis]
|
| 4 |
Han T, Luo Z, Ji L, Wu P, Li G, Liu X, Lai Y. Identification of natural compounds as SARS-CoV-2 inhibitors via molecular docking and molecular dynamic simulation. Front Microbiol 2022;13:1095068. [PMID: 36817101 DOI: 10.3389/fmicb.2022.1095068] [Reference Citation Analysis]
|
| 5 |
Romagnoli A, D'Agostino M, Pavoni E, Ardiccioni C, Motta S, Crippa P, Biagetti G, Notarstefano V, Rexha J, Perta N, Barocci S, Costabile BK, Colasurdo G, Caucci S, Mencarelli D, Turchetti C, Farina M, Pierantoni L, La Teana A, Al Hadi R, Cicconardi F, Chinappi M, Trucchi E, Mancia F, Menzo S, Morozzo Della Rocca B, D'Annessa I, Di Marino D. SARS-CoV-2 multi-variant rapid detector based on graphene transistor functionalized with an engineered dimeric ACE2 receptor. Nano Today 2023;48:101729. [PMID: 36536857 DOI: 10.1016/j.nantod.2022.101729] [Reference Citation Analysis]
|
| 6 |
Saidu H, Aliyu IA, Gwarzo MY, Musa BP, Bala JA, Adeiza MA, Yahaya H, Rogo LD, Siddeeq IA, Saidu A. Pathobiological bases of asthma-COVID-19 interaction: A theoretical viewpoint. AUJMSR 2023;0:1-11. [DOI: 10.25259/aujmsr_44_2022] [Reference Citation Analysis]
|
| 7 |
Okorie CL, Salem I, Davis MJ, Mann JA. A case of late ulceration of infantile hemangioma in the setting of SARS-CoV2 infection. JAAD Case Rep 2023;31:109-11. [PMID: 36406336 DOI: 10.1016/j.jdcr.2022.10.037] [Reference Citation Analysis]
|
| 8 |
Sen R, Sarkar S, Chlamydas S, Garbati M, Barnes C. Epigenetic features, methods, and implementations associated with COVID-19. Omics Approaches and Technologies in COVID-19 2023. [DOI: 10.1016/b978-0-323-91794-0.00008-1] [Reference Citation Analysis]
|
| 9 |
Endo Y, Hickerson BT, Ilyushina NA, Mohan N, Peng H, Takeda K, Donnelly RP, Wu WJ. Identification of a pharmacological approach to reduce ACE2 expression and development of an in vitro COVID-19 viral entry model. J Virus Erad 2022;8:100307. [PMID: 36514715 DOI: 10.1016/j.jve.2022.100307] [Reference Citation Analysis]
|
| 10 |
Devaux CA, Camoin-jau L. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1042200] [Reference Citation Analysis]
|
| 11 |
Maranduca MA, Vamesu CG, Tanase DM, Clim A, Drochioi IC, Pinzariu AC, Filip N, Dima N, Tudorancea I, Serban DN, Serban IL. The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations. Medicina (Kaunas) 2022;58. [PMID: 36556919 DOI: 10.3390/medicina58121717] [Reference Citation Analysis]
|
| 12 |
Cataldo S. Post-Acute Covid-19 Syndrome: manifestazioni cardiovascolari in ottica Pnei e potenziale ruolo della terapia integrata. PNEI REVIEW 2022. [DOI: 10.3280/pnei2022-002009] [Reference Citation Analysis]
|
| 13 |
Dong S, Zhao N, Spragins E, Kagda MS, Li M, Assis P, Jolanki O, Luo Y, Cherry JM, Boyle AP, Hitz BC. Annotating and prioritizing human non-coding variants with RegulomeDB.. [DOI: 10.1101/2022.10.18.512627] [Reference Citation Analysis]
|
| 14 |
Cao J, Yang X, Xiong L, Wu M, Chen S, Xiong C, He P, Zong Y, Zhang L, Fu H, Qi Y, Ying X, Liu D, Hu X, Zhang X. Mechanism of N-0385 blocking SARS-CoV-2 to treat COVID-19 based on molecular docking and molecular dynamics. Front Microbiol 2022;13:1013911. [DOI: 10.3389/fmicb.2022.1013911] [Reference Citation Analysis]
|
| 15 |
Strine MS, Cai WL, Wei J, Alfajaro MM, Filler RB, Biering SB, Sarnik S, Patil A, Cervantes KS, Collings CK, Deweirdt PC, Hanna RE, Schofield K, Hulme C, Konermann S, Doench JG, Hsu PD, Kadoch C, Yan Q, Wilen CB. Kinase-independent activity of DYRK1A promotes viral entry of highly pathogenic human coronaviruses.. [DOI: 10.1101/2022.09.13.507833] [Reference Citation Analysis]
|
| 16 |
Latini A, Vancheri C, Amati F, Morini E, Grelli S, Claudia M, Vita P, Colona VL, Murdocca M, Andreoni M, Malagnino V, Raponi M, Cocciadiferro D, Novelli A, Borgiani P, Novelli G. Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors. J Cell Mol Med 2022. [PMID: 36073344 DOI: 10.1111/jcmm.17492] [Reference Citation Analysis]
|
| 17 |
Bhardwaj V, Dela Cruz M, Subramanyam D, Kumar R, Markan S, Parker B, Roy HK. Exercise-induced myokines downregulates the ACE2 level in bronchial epithelial cells: Implications for SARS-CoV-2 prevention. PLoS ONE 2022;17:e0271303. [DOI: 10.1371/journal.pone.0271303] [Reference Citation Analysis]
|
| 18 |
Bohlin J, Page CM, Lee Y, Pettersson JH, Jugessur A, Magnus P, Håberg SE. Age and sex effects on DNA methylation sites linked to genes implicated in severe COVID-19 and SARS-CoV-2 host cell entry. PLoS ONE 2022;17:e0269105. [DOI: 10.1371/journal.pone.0269105] [Reference Citation Analysis]
|
| 19 |
Bulka CM, Enggasser AE, Fry RC. Epigenetics at the Intersection of COVID-19 Risk and Environmental Chemical Exposures. Curr Environ Health Rep 2022. [PMID: 35648356 DOI: 10.1007/s40572-022-00353-9] [Reference Citation Analysis]
|
| 20 |
Turner AJ, Nalivaeva NN. Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation. Peptides 2022;151:170766. [PMID: 35151768 DOI: 10.1016/j.peptides.2022.170766] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 21 |
Muhammad A, Forcados GE, Sani H, Ndidi US, Adamu A, Katsayal BS, Sadiq IZ, Abubakar YS, Sulaiman I, Abubakar IB, Yusuf AP, Malami I, Ibrahim S, Abubakar MB. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID‐19. Journal of Food Biochemistry. [DOI: 10.1111/jfbc.14079] [Reference Citation Analysis]
|
| 22 |
Zepeda-Cervantes J, Martínez-Flores D, Ramírez-Jarquín JO, Tecalco-Cruz ÁC, Alavez-Pérez NS, Vaca L, Sarmiento-Silva RE. Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19. Viruses 2022;14:94. [PMID: 35062298 DOI: 10.3390/v14010094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 23 |
Sadak O, Sadak F, Yildirim O, Iverson NM, Qureshi R, Talo M, Ooi CP, Acharya UR, Gunasekaran S, Alam T. Electrochemical Biosensing and Deep Learning-Based Approaches in the Diagnosis of COVID-19: A Review. IEEE Access 2022;10:98633-48. [DOI: 10.1109/access.2022.3207207] [Reference Citation Analysis]
|
| 24 |
Hayashi T, Konishi I. Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients. Br J Cancer 2021. [PMID: 34969997 DOI: 10.1038/s41416-021-01685-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Dirican E, Aydin İE, Savrun Ş. COVID-19 hastalarında anjiyotensin 2 (ACE2) genin ekspresyon seviyesi. Cukurova Medical Journal 2021;46:1508-1515. [DOI: 10.17826/cumj.982658] [Reference Citation Analysis]
|
| 26 |
Zannella C, Rinaldi L, Boccia G, Chianese A, Sasso FC, De Caro F, Franci G, Galdiero M. Regulation of m6A Methylation as a New Therapeutic Option against COVID-19. Pharmaceuticals (Basel) 2021;14:1135. [PMID: 34832917 DOI: 10.3390/ph14111135] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 27 |
Sethumadhavan DV, Jabeena CA, Govindaraju G, Soman A, Rajavelu A. The severity of SARS-CoV-2 infection is dictated by host factors? Epigenetic perspectives. Curr Res Microb Sci 2021;2:100079. [PMID: 34725650 DOI: 10.1016/j.crmicr.2021.100079] [Reference Citation Analysis]
|
| 28 |
D’agostino M, Pavoni E, Romagnoli A, Ardiccioni C, Motta S, Crippa P, Biagetti G, Notarstefano V, Barocci S, Costabile BK, Colasurdo G, Caucci S, Mencarelli D, Turchetti C, Farina M, Pierantoni L, Teana AL, Hadi RA, Chinappi M, Trucchi E, Mancia F, Morozzo della Rocca B, D’annessa I, Marino DD. SARS-CoV-2 multi-variant graphene biosensor based on engineered dimeric ACE2 receptor.. [DOI: 10.1101/2021.10.02.21264210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 29 |
Kaneko S, Takasawa K, Asada K, Shinkai N, Bolatkan A, Yamada M, Takahashi S, Machino H, Kobayashi K, Komatsu M, Hamamoto R. Epigenetic Mechanisms Underlying COVID-19 Pathogenesis. Biomedicines 2021;9:1142. [PMID: 34572329 DOI: 10.3390/biomedicines9091142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 30 |
Narożna M, Rubiś B. Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy. Int J Mol Sci 2021;22:8663. [PMID: 34445368 DOI: 10.3390/ijms22168663] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 31 |
Sherman EJ, Emmer BT. ACE2 protein expression within isogenic cell lines is heterogeneous and associated with distinct transcriptomes. Sci Rep 2021;11:15900. [PMID: 34354120 DOI: 10.1038/s41598-021-95308-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 32 |
Beacon TH, Delcuve GP, López C, Nardocci G, Kovalchuk I, van Wijnen AJ, Davie JR. The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes. Clin Epigenetics 2021;13:138. [PMID: 34238359 DOI: 10.1186/s13148-021-01126-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 33 |
Sherman EJ, Mirabelli C, Tang VT, Khan TG, Kennedy AA, Graham SE, Willer CJ, Tai AW, Sexton JZ, Wobus CE, Emmer BT. Identification of ACE2 modifiers by CRISPR screening. bioRxiv 2021:2021. [PMID: 34127970 DOI: 10.1101/2021.06.10.447768] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 34 |
Sherman EJ, Emmer BT. ACE2 protein expression within isogenic cell lines is heterogeneous and associated with distinct transcriptomes. bioRxiv 2021:2021. [PMID: 33791703 DOI: 10.1101/2021.03.26.437218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
